Press Releases
See our press releases below:
06/19/2008: Acceleron to Present at the Jefferies 2nd Annual Healthcare Conference
06/16/2008: Acceleron Doubles Laboratory and Manufacturing Space and Increases Headcount by 40%
06/04/2008: Acceleron to Present at the Needham & Company 7th Annual Biotechnology and Medical Technology Conference
05/13/2008: Acceleron to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
05/07/2008: ACE-011 Preclinical Data Published in the Proceedings of the National Academy of Sciences
03/24/2008: Acceleron Pharma and Celgene Corporation Receive Hart-Scott-Rodino Clearance for ACE-011 Collaboration
03/10/2008: Acceleron to Present at the Cowen and Company 28th Annual Health Care Conference
02/20/2008: Acceleron Pharma Announces Global Collaboration with Celgene Corporation on ACE-011 Program for Cancer-Related Bone Loss
01/23/2008: Acceleron Pharma Receives Grant for ACE-011 from the Multiple Myeloma Research Foundation
11/20/2007: Acceleron Pharma to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
11/01/2007: Acceleron Pharma to Present at the Massachusetts Biotechnology Council’s 9th Annual MASS Opportunities Investment Conference
10/31/2007: Acceleron Pharma to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
10/30/2007: Acceleron Pharma Completes $31M Series C Financing
10/18/2007: Acceleron Pharma’s ACE-031 Increases Muscle Mass In a Preclinical Model of Glucocorticoid-induced Muscle Loss
10/05/2007: Acceleron Pharma Website Awarded “Pharmaceutical Industry Standard of Excellence” by the Web Marketing Association
10/02/2007: Acceleron Pharma to Present at the Natixis Bleichroeder Hidden Gems Conference
09/24/2007: Acceleron Pharma Appoints Niels Borgstein, M.D. as Vice President, Medical Research
09/20/2007: Acceleron Pharma to Present at the UBS 2007 Global Life Sciences Conference
09/20/2007: Acceleron Pharma's ACE-011 Increases Bone Mineral Density and Bone Strength in Preclinical Studies in Non-Human Primates
09/18/2007: Acceleron Pharma Appoints John L. Knopf, Ph.D., as Chief Executive Officer
09/18/2007: Acceleron Pharma Presents Positive Phase 1 Results Demonstrating ACE-011 Increases Markers of Bone Formation
08/06/2007: Acceleron Pharma to Present ACE-011 Bone Growth Data at the ASBMR 29th Annual Meeting
07/31/2007: Acceleron Pharma to Present at the 27th Annual Canaccord Adams Global Growth Conference
06/26/2007: ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
05/14/2007: Acceleron Pharma’s ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
04/24/2007: Acceleron Pharma Appoints James Desiderio, Ph.D. as Vice President, Program Management
03/29/2007: Acceleron Pharma Appoints Robert Steininger as Senior Vice President, Manufacturing
03/07/2007: Acceleron Pharma to Present at the Cowen 27th Annual Health Care Conference
11/03/2006: Acceleron Pharma to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
10/30/2006: Acceleron Pharma to Present at the MBC's MASS Opportunities Conference
09/18/2006: Acceleron Pharma Presents ACE-011 Preclinical Data Demonstrating Both Anabolic and Anti-Resorptive Properties
09/12/2006: Acceleron Pharma to Present ACE-011 Preclinical Data at the Annual Meeting of the American Society for Bone and Mineral Research
08/02/2006: Acceleron Pharma Closes $30M Series B Financing
06/21/2006: Acceleron Initiates Phase 1 Clinical Trial of ACE-011, a Novel Treatment for Bone Loss
05/16/2006: Acceleron Pharma Appoints Matthew L. Sherman, M.D. as Chief Medical Officer
06/14/2004: Acceleron Pharma Appoints Glenn Batchelder as CEO and Adds Richard F. Pops to Board of Directors
02/13/2004: Acceleron Pharma, Developing Drugs to Treat Musculoskeletal and Metabolic Disorders, Secures $25 Million in Series A Funding
BACK TO TOP
